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Abstract
We recently demonstrated the utility of quantifying spontaneous pain in mice via the blinded coding of facial
expressions. As the majority of preclinical pain research is in fact performed in the laboratory rat, we attempted to
modify the scale for use in this species. We present herein the Rat Grimace Scale, and show its reliability, accuracy,
and ability to quantify the time course of spontaneous pain in the intraplantar complete Freund’s adjuvant,
intraarticular kaolin-carrageenan, and laparotomy (post-operative pain) assays. The scale’s ability to demonstrate the
dose-dependent analgesic efficacy of morphine is also shown. In addition, we have developed software, Rodent
Face Finder
®, which successfully automates the most labor-intensive step in the process. Given the known
mechanistic dissociations between spontaneous and evoked pain, and the primacy of the former as a clinical
problem, we believe that widespread adoption of spontaneous pain measures such as the Rat Grimace Scale
might lead to more successful translation of basic science findings into clinical application.
Introduction
Despite great advances in basic understanding of mole-
cular pain mechanisms and considerable investment by
industry, translational achievements in analgesic drug
development have been extremely limited. Many believe
that the high attrition is due, at least in part, to the
poor predictivity of current animal models of pain [1].
As in vivo animal research remains the mainstay of
analgesic drug development [2,3], much recent effort
has been devoted to reexamining pain testing para-
digms in laboratory animals. Of the criticisms directed
at the status quo in rodent algesiometry, one of the
most common is that the vast majority of preclinical
studies measure withdrawal responses to evoking ther-
mal and mechanical stimuli instead of the more clini-
cally important spontaneous pain [4]. Although a
number of rodent behaviors are correlated in time
with injuries that presumably also produce
spontaneous pain, in many cases it has been difficult
to demonstrate that these behaviors display specificity
and sensitivity as measures of pain [5].
Because of the known utility of facial coding scales
(based on the facial action coding system; FACS) [6] for
the quantification of pain in non-verbal human popula-
tions [see [7]], and the prediction by Darwin that nonhu-
man animals exhibit similar facial expressions to
emotional states as do humans [8], we recently developed
and characterized the Mouse Grimace Scale (MGS) [9]. It
consists of five facial “action units” (orbital tightening,
nose bulge, cheek bulge, ear position, and whisker
change) scored on a 0-2 scale for their prominence in
still photographs taken from digital video of mice in
either a baseline or pain condition. We demonstrated
that the MGS displays high accuracy and reliability, is
useful for quantifying pain of moderate duration (from
several minutes to approximately 1 day), is sensitive to
detecting weak analgesic effects, and may represent a
measure of the animal’s affective response to pain [9].
The purpose of the present work was two-fold. First,
despite increasing use of the mouse over the past few
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ject of preclinical pain research [1]. The evolutionary
stability of facial expression [7,8] would clearly predict
that the MGS could be translated to the rat. Second, the
main practical disadvantage of the MGS is the labor-
intensive nature of one step in the process: grabbing
individual face-containing frames from digital video,
which is hampered by uncooperative subjects (not look-
ing directly at the camera) or otherwise poor optics due
to motion blurring. The utility of this method would
thus be greatly improved by automated frame grabbing.
We report here the development of the Rat Grimace
Scale (RGS), its ability to quantify pain in three common
algesiometric assays (intraplantar complete Freund’s
adjuvant, intraarticular kaolin/carrageenan, and laparot-
omy), and the development of Rodent Face Finder
® soft-
ware for automated generation of scoring-ready still
photographs of both mouse and rat faces.
Materials and Methods
In all experiments, male and female rats were used in
equal numbers [10]. No sex differences were observed
and so data were combined for reported analyses.
Animals
All subjects were Wistar rats, aged 6-8 weeks (200-250
g), obtained from Charles River Laboratories (Boucher-
ville, QC). Rats were housed in groups of 2-4, under a
12:12-hour light cycle (lights on at 07:00 h) in a tem-
perature-controlled environment (20 ± 2°C) with ad lib
access to food (Prolab RHM 2500) and tap water. Each
nociceptive assay utilized a separate cohort of rats, such
that no subject participated in more than one assay. All
studies were approved by a local animal care and use
committee, and were consistent with national guidelines.
Inflammatory assays
Inflammatory assays were used in this study since the
limited duration of facial grimacing is not appropriate
for neuropathic assays. Complete Freund’sa d j u v a n t
(CFA), kaolin and carrageenan were all obtained from
Sigma (St. Louis, MO). In the intraplantar CFA model
[11], rats were injected with 50% CFA, in a 150 μl injec-
tion volume, into the plantar surface of one hind paw.
Rats (n = 10) were tested before, and 1 h, 4 h, 6 h, 24 h
and (in a separate cohort; n = 8) 48 h and 7 days post-
injection. In the rat intraarticular kaolin/carrageenan
model [12], 2% kaolin and 2% carrageenan were succes-
sively injected (separated by 10 min), under isoflurane/
oxygen anesthesia, into one knee joint, each in a volume
of 200 μl. Rats (n = 6) were tested before, and 3 h, 6 h,
and 12 h post-injection. Group sizes were based on our
experience using similar assays in mice [9].
Laparotomy
A laparotomy, designed to mimic a sham ventral ovar-
iectomy [13], was performed under isoflurane/oxygen
anesthesia. Following shaving and disinfection, a 1-cm
midline incision was made using a scalpel. Muscle layers
were closed with polydioxanone suture 5-0 (Vicryl
®;
Ethicon, Somerville, NJ) and skin edges apposed using
t i s s u eg l u e( V e t b o n d
®;3 M ,S t .P a u l ,M N ) .R a t s( n =6 )
w e r et e s t e db e f o r e ,a n d1h ,4h ,6ha n d1 2hp o s t -
surgery.
Morphine
Morphine sulfate was obtained from Sandoz Canada.
Mice were injected with physiological saline (10 ml/kg)
or 1, 2, or 5 mg/kg morphine (n = 4-8/dose), adminis-
tered 5.5 h after CFA (see above) and 15 min before the
start of 30-min digital video recording (see below).
Digital video
Rats (two at a time) were placed on a table top in cubicles
(21 × 10.5 × 9 cm high) with walls of transparent Plexi-
glas
® and a separating wall of removable stainless steel.
One digital video camera was placed on either side of the
apparatus in order to maximize the opportunity for clear
head shots. Rats were digitally videotaped using high-reso-
lution (1920 × 1080) digital video cameras (Sony High
Definition Handycam
® Camcorder; model HDR-CX100)
for 30 min immediately prior to injection or surgery (base-
line or no pain photos), and for 30 min at various time
points after injection or surgery (pain photos).
Automated frame capture using Rodent Face Finder
®
Previous to the development of Rodent Face Finder
®
(RFF), we extracted images manually from digital video.
Using Windows Media Player, individual frames of the
resultant AVCHD video files were “grabbed” and
cropped (so that body position was no longer visible)
using the Windows 7 Snipping Tool whenever a clear,
unobstructed head shot was observed. This process is
considerably labor-intensive, and a C++ program (using
the Open CV2.0 library; http://opencv.willowgarage.
com), RFF was developed to automate it.
RFF detects rodent eyes and ears using boosted cascades
of Haar classifiers [14], which use differences between
pixel intensities in small rectangular regions (Haar-like
features) to capture textural and orientation information,
a n dc o m b i n et h er e s p o n s ef r o mm a n ys u c hr e g i o n st o
make predictions on whether a specific sub-region in an
image contains an eye or ear. The precise regions and cut-
offs used by the cascades were obtained by Haar training,
using approximately 500 cropped images of ears and eyes
from both baseline and pain-experiencing rodents as posi-
tive examples, and a comparable number of non-face-
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ing examples. The resulting detectors were used to scan
each video frame for eyes and ears, at a variety of scales.
Frames with at least one eye and at least one ear detected,
and satisfying bounds on the distance between them to
reduce false positives, were flagged as candidates for scor-
ing. Figure 1 illustrates a vi d e of r a m ef l a g g e db yR F Ff o r
scoring.
To reduce the number of images for manual scoring,
and to minimize blurring due to rapid motions such as
grooming, among all the candidate video frames in each
3-min time interval, only the three with the smallest aver-
age absolute pixel difference relative to the previous
video frame (1/30
th of a second earlier) were saved as
images. Both the feature detection and motion estimation
were restricted to zones of the video corresponding to
single cages, with the left and right cages analyzed
separately.
From each 3-min time interval, the single image most
suitable for manual RGS scoring was manually selected
from among the candidate images. For some intervals,
no candidate images were extracted by RFF, which can
occur if the rodent does not face either camera during
this interval, or due to false negatives in the program. In
some intervals with no candidate images, images were
extracted manually.
RGS coding
Image files were then copied into PowerPoint, one image
per slide. A PowerPoint macro (http://www.tushar-mehta.
Figure 1 Uncropped image identified by RFF for RGS scoring.B o x e s :b l u e ,t o t a lr e g i o na n a l y z e d ;r e d, detected eye; green, detected ear;
purple, estimated face region.
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used to randomize the slide order. Identifications were
removed in order to ensure that subsequent coding was
performed blind.
Randomized and unlabeled photos were presented on
a large, high-resolution computer monitor, one at a
time. For each photo, the scorer assigned a value of 0, 1
or 2 for each of the four RGS action units (see section
3.1 and Figure 1). In every case, a score of “0” indicated
high confidence of the scorer that the action unit was
absent. A score of “1” indicated either high confidence
of a moderate appearance of the action unit, or equivo-
cation over its presence or absence. A score of “2” indi-
cated the detection of an obvious appearance of the
action unit, with high confidence.
Accuracy and reliability determination
A detailed handout was prepared and distributed (by S.
G.S.) to members of the J.S.M. lab, explaining each fea-
ture and providing prototypic photos for each intensity
score (0-2) of each action unit. Five postdoctoral, gradu-
ate or undergraduate student coders were then given
104 randomized, unlabeled photos (half no pain;h a l f
CFA pain) in order to assess inter-rater reliability and
accuracy of the RGS. Reliability was quantified by com-
paring average action unit scores across coders, using
the intraclass correlation coefficient (ICC) [15]. Accu-
racy was determined by global pain vs. no pain dichoto-
mous judgments also made by the scorers.
Statistical analyses
All statistical analyses were performed using Systat v.11
(SPSS Inc.), with a criterion a = 0.05, except for the
ICC, which was calculated using SPSS v. 17. Time-
course data were analyzed using repeated measure
ANOVA; group/dose differences by one- or two-way
ANOVA followed where appropriate by Dunnett’sc a s e -
comparison posthoc test. Half-maximal analgesic doses
(AD50s) were calculated using the method of Tallarida
and Murray [16] as implemented by FlashCalc 40.1
®
software (M. Ossipov, University of Arizona).
Results
The RGS compared to the MGS
Preliminary attempts to use the existing MGS to score
pain in rats were broadly successful (data not shown),
but with increasing experience we noticed one striking
difference between the “pain face” of the two rodent
species. In the mouse, the nose and cheek at baseline
have a smooth appearance, whereas in the presence of
pain distinct bulges are noted in both the nose and the
cheek regions [9]. By contrast, at baseline the nose and
cheek regions of the rat display distinct bulging, and
with pain the bridge of the nose flattens and elongates,
causing the whisker pads to flatten. The flattening of
normal bulging in the nose and cheek appear to always
occur together, such that a single action unit, which
we call Nose/Cheek Flattening,a p p e a r st os h o wt h e
highest correlation with the presence of pain in the
rat. This major change renders the RGS much more
sensitive and accurate in detecting pain in rats than
the MGS.
Thus, the four action units of the RGS (illustrated in
Figure 2) are as follows:
1. Orbital Tightening
Rats in pain display a narrowing of the orbital area,
manifesting either as (partial or complete) eye closure or
eye “squeezing.”
2. Nose/Cheek Flattening
Rats in pain display successively less bulging of the nose
and cheek (see above), with eventual absence of the
crease between the cheek and whisker pads.
3. Ear Changes
The ears of rats in pain tend to fold, curl and angle for-
wards or outwards, resulting in a pointed shape. The
space between the ears may appear wider.
4. Whisker Change
The whiskers of rats in pain move forward (away from
the face) from the baseline position, and tend to bunch,
giving the appearance of whiskers standing on end.
More detailed descriptions may be found in the RGS
training manual, provided as Additional File 1.
Reliability and accuracy of the RGS
Reliability and accuracy of the RGS in quantifying CFA
pain is shown in Figure 3. The overall ICC was 0.90
(Figure 2a), exactly the same as that of the MGS on the
abdominal constriction test [9]. Reliability was statisti-
cally identical for front-view (two eyes present) versus
side-view (one-eye present) photos. All four action units
displayed high inter-rater reliability, with ICCs ranging
from 0.86 (Nose/Cheek Flattening)t o0 . 9 6( Orbital Tigh-
tening). On average, the scorers achieved an accuracy
rate of 81.6% (Figure 2b); of inaccurate pain/no pain
determinations, false alarms (8.2%) were slightly more
common than misses (10.3%). Individual scorers’ accu-
racy ranged from 76.0-87.5%. Front-view and side-view
photos were scored with equal accuracy.
Quantification of pain in three nociceptive
assays using the RGS
The extent and time course of pain in three nociceptive
assays was quantified using the RGS (Figure 4). Baseline
RGS scores were the same in each experiment (F2,19 =
1.7, p = 0.21), and in every case RGS scores increased
from baseline levels by 2-4-fold, and then returned to
baseline levels. Repeated measures ANOVA was per-
formed on RGS scores (including baseline), followed by
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correction for multiple comparisons.
In the CFA assay (analyzed up to 24 h), ANOVA
revealed a highly significant effect of repeated measures
(F4,36 =9 . 2 ,p< 0.001). Significant increases from base-
line were observed at 4 h, 6 h and 24 h post-injection.
Because the 24-h time point still showed significant gri-
macing, a separate cohort of rats was tested at 48 h and
7 days post-injection. Although the 48-h time point was
significantly increased from its own baseline (F2,14 =9 . 1 ,
p< 0.005; posthoc test for repeated measures, p< 0.05),
increased variability was observed such that grimacing
was observed in some rats but not others. In any case,
by day 7 all rats had returned to baseline levels.
In the kaolin/carrageenan assay, ANOVA revealed a
highly significant effect of repeated measures (F3,15 =
Figure 2 The four action units of the Rat Grimace Scale (RGS). See text for details.
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observed at 3 h post-injection, with a strong trend to
increased scores (p = 0.08) observed at 6 h. RGS scores
were at baseline levels by 12 h post-injection.
Finally, in the laparotomy assay, ANOVA revealed a
highly significant repeated measures effect (F4,20 =8 . 0 ,
p< 0.001). A significant increase from baseline was
observed at 1 h, 4 h and 6 h post-injection, but not at
12 h post-injection.
Individual action units
To compare the utility of the four action units comprising the
RGS, we analyzed difference in scores (pain - no pain)o fd a t a
from all three assays combined. To facilitate a valid compari-
son, the single time point showing maximal RGS scores in
each assay (6 h for CFA, 3 h for kaolin/carrageenan, and 4 h
for laparotomy) was used to supply pain photos.
No differences in the RGS difference scores were
noted among the four action units (one-way ANOVA:
Figure 3 Interrater reliability (a) and accuracy (b) of the RGS in the quantification of pain. In both cases 100 photographs were scored,
half pain (CFA) and half no pain (baseline). Scorer 1 developed the RGS, and trained the others; the signal detection data represent the average
of all six scorers. Hits: pain photograph scored as pain; Correct Rejections: no pain photograph scored as no pain; Misses: pain photograph scored
as no pain; False Alarms: no pain photograph scored as pain. ICC: intraclass correlation coefficient (see text).
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(Figure 5a). Correlations between each action unit and
the average (i.e., overall) difference scores ranged from r
= 0.72-0.86 (all p≤ 0.001). Averaging all four action
units appears to improve the signal-to-noise ratio, as a
smaller S.E.M. was observed for the average score (0.06)
than for any of the individual action units (0.07-0.10). A
comparison of action unit difference scores by nocicep-
tive assay (Figure 5b) revealed only one instance of a
significant difference in action unit “strength” between
assays: the Ear Changes action unit was significantly
more prominent after laparotomy than in the other
assays (p< 0.01; corrected). However, this appears to be
just an exaggerated example of a general trend whereby
laparotomy produced higher peak RGS scores (see Fig-
ure 5b “AVERAGE”).
Morphine Analgesia
If the RGS is truly quantifying pain levels, then it must
be able to detect the pain-inhibiting effect of known
analgesics such as morphine. Figure 6 shows dose-
dependent inhibition (F3,16 =4 . 4 ,p< 0.05) of facial gri-
macing caused by CFA (at the 6 h time point) by mor-
phine. The AD50 of morphine was calculated as 0.8 mg/
kg (95% confidence interval: 0.4-1.2 mg/kg).
Discussion
We report here the development, reliability, accuracy,
analgesic sensitivity, and utility of the RGS, a method to
quantify spontaneous pain in the laboratory rat. In addi-
tion, we have developed an automated system–the RFF
software package–that can successfully extract scorable
image files from digital video, previously the most labor-
intensive step in the application of the RGS (or MGS).
The RFF can be obtained directly from one of the
authors (ODK at king@bbri.org) upon request by inter-
ested individuals, at no charge for academic users and
via licensing agreement for corporate users.
RGS vs. MGS
As predicted by the evolutionary conservation of facial
expressions of emotions [8], including pain [7], the
“pain face” of the rat was found to be broadly similar to
that of the mouse, with three of the RGS action units
essentially unchanged from the MGS. A major exception
is the nose and cheek, whereby pain in the mouse
results in bulging, but in the rat bulging occurs naturally
and this characteristic actually diminishes when the rat
is in pain.
Observed accuracy rates for the RGS are lower than
those observed in the MGS using similar high-definition
video (97% by S.G.S.) [9], but still far above chance
Figure 4 Quantification of spontaneous pain in three
nociceptive assays: intraplantar CFA (a), intraarticular kaolin/
carrageenan (b), and postoperative (laparotomy) pain (c). Bars
represent mean ± SEM RGS score (n = 6-10 rats/assay). *p< 0.05;
**p< 0.01 compared to baseline (Bonferroni-corrected).
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MGS, another well-validatedp a i n - r e l a t e db e h a v i o r
(abdominal constrictions) was used to verify the exis-
tence of spontaneous pain in each subject, whereas here,
using CFA, we were forced to simply assume its exis-
tence. This fact likely accounts for the lower accuracy
values obtained, since rats in some of the pain photo-
graphs may not have been, at that precise moment,
actually in pain, which would artificially inflate the miss
rate.
Inter-rater reliability of the RGS was very high, as high
as on the MGS. We note, however, that this was only
tested in five individuals in one laboratory. We encou-
rage others to use the method so that true reliability
and accuracy rates can be ascertained.
Time course of inflammatory pain
Peak RGS scores were observed at 6 h post-CFA, 3 h
post-kaolin/carrageenan, and 4 h post-laparotomy. It is
tempting to conclude that this represents the peak of
spontaneous pain in these assays, as opposed to allody-
nia. There are, of course, very few extant studies where
spontaneously emitted behaviors have been recorded in
t h e s ea s s a y s ,a n de v e nt h e ni t ’s not clear that what is
being measured is spontaneous pain (as opposed to
mechanical allodynia), or even pain at all [1,4,5]. In an
early study using intraplantar 100% CFA in the rat [17],
a number of behavioral characteristics including food
intake, open field behavior, and core body temperature
were altered by CFA, some for over 5 weeks. In con-
trast, Djouhri and colleagues [18], using spontaneous
Figure 5 Prominence of individual action units at the peak of apparent spontaneous pain in each assay (see Figure 4). Bars represent
mean ± SEM difference scores (pain - no pain; n = 23 rats). Overall, all action units were equally prominent statistically (a), and this was also true
in each assay considered separately (b). **p< 0.01 (Bonferroni-corrected) compared to other assays. K/C = kaolin/carrageenan.
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rats, noted that all rats displayed foot lifting 1 day after
injection, but less than 20% did by day 2 and none did at
4-7 days post-injection. Using a suite of behaviors (includ-
ing muscle twitching, back arching, staggering, and
abdominal writhing), Roughan and Flecknell [19] con-
cluded that postoperative pain after laparotomy decreased
significantly after 3-5 h post-surgery. Using exploratory
activity and conditioned operant responding for sucrose
pellets as the measure, in contrast, Martin et al. [20]
observed changes after surgery lasting up to 2-3 days.
The time course of mechanical allodynia and thermal
hyperalgesia in these models is better known, albeit
dose- and strain-dependent. The first study to use 50%
CFA in the rat observed peak thermal hyperalgesia at 4
h post-injection and a return to baseline by 15 days;
mechanical allodynia peaked at 2 days post-injection
and was resolved by 5 days [21]. The duration of
changes in the other two models is much more limited.
Thermal hyperalgesia in the kaolin-carrageenan model
was found to peak at 8-12 h and resolve by 2 days post-
injection [12]. Electrophysiological experiments have
shown that primary afferent fibers in the joint are sensi-
tized in the kaolin-carrageenan model 3-6 h post-injec-
tion [22]. After laparotomy in the Wistar rat,
mechanical allodynia was noted from 2.5-6.5 h post-sur-
gery [13], although in a recent study (involving in addi-
tion to the incision the implantation of a radiotelemetry
transmitter) significant allodynia was observed for 9
days [23].
Overall there is good concordance between the time
course of inflammatory pain inferred from the literature
and our current data. It is important to note, however,
that the disappearance of the facial grimacing may not
necessarily represent the disappearance of spontaneous
pain, as there are adaptive advantages to inhibiting a
“pain face” as soon as possible.
New approaches to algesiometry
The problematic symptoms of chronic pain in humans
include spontaneous pain, numbness, dysesthesias, and
evoked (mechanical, heat and cold) hypersensitivity. But
these are not equally common, or of equal concern. For
both neuropathic and non-neuropathic pain, sponta-
neous or ongoing pain (especially deep pain) is far more
prevalent than evoked pain, especially touch- and
warmth-evoked pain [24,25]. Spontaneous pain is also
rated as more bothersome, and more highly correlated
with global ratings of pain severity [24]. Despite this
clinical reality, preclinical studies of pain are strongly
weighted towards the study of mechanical and thermal
hypersensitivity states, largely for reasons of practicality
and inertia [4].
However, new approaches to measuring pain (and/or
the impact of pain) appear to be gaining popularity;
these include thermal preference/escape models [e.g.,
[26,27]], conditioned place aversion [28,29], condi-
tioned place preference (to pain inhibition) [30,31],
and ultrasonic vocalization [32]. Compared to these,
facial expression coding has the considerable advan-
tage that no subject training or special equipment
(other than a video camera) are required. It also pro-
vides the advantage of more complete blinding of the
experimenter [33], since during scoring the presence
or absence of an inflamed or guarded hind paw is
completely obscured. Quantifying pain by facial
expression is also the only technique of practical value
in veterinary medicine (including laboratory animal
welfare), as it can in fact be performed in real time by
trained investigators, animal technicians and/or
veterinarians.
The major disadvantages to blinded facial expression
coding for research purposes are the labor-intensive nat-
ure of frame grabbing, a problem now largely solved
with RFF software, and the limited duration (< 48 h) of
the pain face. This limitation is imposed by the nature
of facial grimacing itself, which is also not observed in
human chronic pain patients. Thus, the study of real-
time spontaneous pain in chronic neuropathic assays
awaits the development of a useful dependent measure.
Additional material
Additional file 1: Rat Grimace Scale (RGS): The Manual. This training
manual describes detailed procedures for the implementation of the
RGS.
Figure 6 Quantification of morphine analgesia by the RGS.
Morphine was administered 5.5 h after CFA and 15 min before the
start of 30-min digital video recording. Bars represent ± SEM RGS
score (n = 4-10 rats/dose). *p< 0.05 compared to saline (0) by
Dunnett’s case-comparison posthoc test (one-way).
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